PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery

Summary

The primary objective of this study is to characterize the pharmacokinetic (PK) profile of EXPAREL when administered via local wound infiltration to subjects undergoing open spinal fusion or reconstructive surgery. The secondary objectives of this study are to assess the safety, tolerability, and efficacy of EXPAREL in this surgical model.

Timeline

Start

2016-12

Primary completion

2017-09

Completion

2017-09

Drugs

Indications

No indication recorded.